GC
IDXX icon

Gratus Capital’s Idexx Laboratories IDXX Stock Holding History

Gratus Capital’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		$2.3M Buy
4,727
+5
+0.1% +$2.51K 0.09% 137
2024
Q1 		$2.55M Sell
4,722
-1,130
-19% -$618K 0.12% 121
2023
Q4 		$3.25M Sell
5,852
-39
-0.7% -$18.3K 0.18% 99
2023
Q3 		$2.58M Buy
5,891
+39
+0.7% +$19.4K 0.17% 95
2023
Q2 		$2.94M Sell
5,852
-1,290
-18% -$618K 0.2% 87
2023
Q1 		$3.57M Buy
+7,142
New +$3.42M 0.27% 75

Other funds holding IDXX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $13.6B AUM 7.6% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Gratus Capital's IDXX Position: Q2 2024 in Review

Gratus Capital increased its Idexx Laboratories (IDXX) stake by 0.11% in Q2 2024, buying an estimated $2.51K and bringing the position to 4,727 shares worth $2.3M. The position accounts for 0.09% of the portfolio, ranked #137.

Gratus Capital first reported a position in IDXX in Q1 2023 and has held it in 6 quarters since. The position peaked at $3.57M in Q1 2023. 1,110 funds tracked by Wall St. Rank hold IDXX as of Q2 2024.

  • Gratus Capital held 4,727 shares of Idexx Laboratories worth $2.3M as of Q2 2024.
  • Gratus Capital bought 5 Idexx Laboratories shares in Q2 2024, an estimated $2.51K.
  • Idexx Laboratories made up 0.09% of Gratus Capital's portfolio in Q2 2024, its #137 holding.
  • Gratus Capital first reported a position in Idexx Laboratories in Q1 2023 and has held it in 6 quarters since.
  • Gratus Capital's Idexx Laboratories position peaked at $3.57M in Q1 2023.
  • 1,110 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2024.

Based on Gratus Capital's 13F filing for Q2 2024, filed 25 Jul 2024.